Issuer · CIK 0001124105
GYRE — GYRE THERAPEUTICS, INC.
Recent filings
- Jun 15, 2026·Form 4·Sell$17.3K
GYRE/GYRE THERAPEUTICS, INC.
Ye Weiguo · Chief Operating Officer
Mechanical filing
AI thesis skipped - Jun 10, 2026·Form 4·Other—
GYRE/GYRE THERAPEUTICS, INC.
Bergmann Joshua Benjamin · GC and Corporate Secretary
Mechanical filing
AI thesis skipped - Jun 10, 2026·Form 4·Other—
GYRE/GYRE THERAPEUTICS, INC.
Luo Ying · Chief Executive Officer
Mechanical filing
AI thesis skipped - Jun 8, 2026·Form 4·Sell$120K
GYRE/GYRE THERAPEUTICS, INC.
Ye Weiguo · Chief Operating Officer
Mechanical filing
AI thesis skipped - May 27, 2026·Form 4·Sell$24.4K
GYRE/GYRE THERAPEUTICS, INC.
Ye Weiguo · Chief Operating Officer
Mechanical filing
AI thesis skipped - May 22, 2026·Form 4·Sell$78.8K
GYRE/GYRE THERAPEUTICS, INC.
Ye Weiguo · Chief Operating Officer
12conviction - May 21, 2026·Form 4·Other—
GYRE/GYRE THERAPEUTICS, INC.
Zhang Ping · director
Mechanical filing
AI thesis skipped - May 8, 2026·Form 4·Sell$81.5K
GYRE/GYRE THERAPEUTICS, INC.
Luo Ying · Chief Executive Officer
22conviction - May 7, 2026·Form 4·Other—
GYRE/GYRE THERAPEUTICS, INC.
GNI Group Ltd. · 10pct_owner
8conviction - May 7, 2026·Form 4·Other—
GYRE/GYRE THERAPEUTICS, INC.
Eastling Thomas Wilson · Chief Financial Officer
Mechanical filing
AI thesis skipped